The Small Biotech Scaring Big Pharma
Nov 07, 2019
It really is the biggest “hidden” opportunity on Wall Street. You see, while everyone else has been focused on crypto and pot stocks, we’ve been focused where no one else was looking: the biotech sector. As a result, we’ve had a different biotech stock taken over every 42 days… I’m truly grateful to be able … Continue reading “The Small Biotech Scaring Big Pharma”More >> More >>
China has become our Frankenstein monster…
Oct 14, 2019
The geniuses in Washington told us that the more China traded with us, the freer they would become. It wouldn’t be long before the Communist Party melted away and, in its place, sprung a Jeffersonian Democracy.
Turns out they had it all backwards…More >> More >>
“Where you gonna go?”
Oct 03, 2019
Where you gonna go? That’s the question I’ve asked myself as the market has sold off in recent days. Are you gonna go into 30-year U.S. Treasury bonds? They’re yielding 2.085%. Imagine that. You get 2% a year for lending the government money for 30 years! Not unless you have to. Where you gonna go? … Continue reading ““Where you gonna go?””More >> More >>
The last picture I could take on 9/11.
Sep 11, 2019
I remember that day being crisp. The kind of fall day that lets you know summer isn’t coming back. I was dressed to impress that morning. My best suit. I had an 8:30 meeting at the building next door to the New York Stock Exchange. A firm I was trying to do business with. For … Continue reading “The last picture I could take on 9/11.”More >> More >>
Lunch Costs How Much?!?
Aug 08, 2019
Another thing that amazed me was how expensive an average lunch was. Just an average lunch was $50. I’m talking about eating at an average American restaurant in the middle of a city like Chattanooga, TN. Two adults, no alcohol and two young children eating off the kid’s menu! It’s like $50 is the new $20.More >> More >>
How to Invest in Biotech Stocks
Jun 13, 2019
The stocks we recommend at Biotech Insider are in either the start-up phase or the growth phase of their life cycle.
By nature that means these investments are high-risk, high-return investments. It also means they’re going to be very volatile. Sometimes comically volatile.
That’s why most professional investors look at small cap biotech investing like venture capital investing. And just like venture capital investing, fortunes can be made even when you know in advance that you will lose money on a good portion of the investments you make.
In fact, let me just say right now that here at Biotech Insider we expect 30% of the investments we make to lose money.More >> More >>
All of Wall Street Says to Buy Uber. We Take a Look…
Jun 06, 2019
25 Analysts Started Coverage of Uber. None of Them Think the Stock is a Sell. We Take a Look.More >> More >>
Income Investing Part II: How to Get 12% Yields Today
May 16, 2019
Last week, we discussed the benefits of investing in Business Development Companies (BDCs) for investors seeking yield. Our hunt for yield in a low interest rate environment continues this week as we turn our focus to Master Limited Partnerships (MLPs).More >> More >>